Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
HCW Biologics Inc. is a clinical-stage biopharmaceutical company developing proprietary immunotherapies targeting age-related and chronic inflammatory diseases, including cancer, autoimmune, and neurodegenerative conditions. Utilizing innovative platforms like TOBI and TRBC, it creates multi-functional fusion proteins and immune cell engagers to modulate immune responses. The company focuses on immunotherapies that reduce senescent cells and inflammation, aiming to extend health span and improve quality of life.
This description was generated via AI from an annual report. Updated about 1 year ago.